Nymox Pharmaceutical CorpのEBITDA
Nymox Pharmaceutical CorpのEBITDAは何ですか。
Nymox Pharmaceutical CorpのEBITDAは-11.51$です。
EBITDAの定義は何ですか。
EBITDA は、会社の営業成績を表す利息、税金、減価償却費および償却費を控除する前の利益です。
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
NASDAQのセクタHealth CareにおけるEBITDAの企業と比べるNymox Pharmaceutical Corp
Nymox Pharmaceutical Corpは何をしますか。
nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.
Nymox Pharmaceutical Corpと類似のebitda
- HomeStreet IncのEBITDAは-11.56$です。
- Nanoxplore IncのEBITDAは-11.55CAD$です。
- Shah FoodsのEBITDAは-11.54₨です。
- Next ScienceのEBITDAは-11.53$です。
- Greenrose AcquisitionのEBITDAは-11.53$です。
- Great WaterのEBITDAは-11.52¥です。
- Nymox Pharmaceutical CorpのEBITDAは-11.51$です。
- Poseidon NickelのEBITDAは-11.49AUD$です。
- Aurania ResourcesのEBITDAは-11.47CAD$です。
- Experience CoのEBITDAは-11.47AUD$です。
- Heidelberg Pharma AGのEBITDAは-11.45€です。
- Guru Online ()のEBITDAは-11.45HKD$です。
- The Real Brokerage IncのEBITDAは-11.45$です。